SCHEMBL7216382

SCHEMBL7216382

NC(=O)c1ccc(N)c(N)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.46
ERN1 O75460 1/20 0.44
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 4/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
PARP1 P09874 1/20 0.39
MMP2 P08253 1/20 0.38
BCAT2 O15382 1/20 0.38
GRK6 P43250 1/20 0.37
ATM Q13315 1/20 0.35
DGAT1 O75907 1/20 0.35
LMNA P02545 1/20 0.35
MAP2K3 P46734 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1162152 0.82 MMP2 (0.57) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL8761666 0.81 IKBKB (0.44) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL3424158 0.80 ERN1 (0.54) ERN1ALDH1A1KDM4EMAPTHPGD
SCHEMBL30211643 0.80 ERN1 (0.54) ERN1ALDH1A1KDM4EMAPTHPGD
SCHEMBL12316432 0.78 ERN1 (0.42) IKBKBERN1ALDH1A1KDM4EMAPT
SCHEMBL10661542 0.76 PARP1 (0.41) IKBKBALDH1A1KDM4EMAPTHPGD
SCHEMBL7405207 0.75 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL6129036 0.74 KMT2A (0.41) IKBKBERN1ALDH1A1KDM4EMAPT
SCHEMBL16369634 0.74 MAPT (0.47) IKBKBERN1ALDH1A1KDM4EMAPT
SCHEMBL28078633 0.74 ERN1 (0.39) IKBKBERN1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1137100-C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family ��ʲ 2004-02-04 CN disclosed
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed
US-5679683-A USEFUL FOR TREATING CANCER, ARTHRITIS, PSORIASIS, VASCULAR RESTENOSIS AND ANGIOGENESIS WARNER-LAMBERT COMPANY (US) 1997-10-21 US disclosed
CN-1139430-A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family WARNER LAMBERT CO (US) 1997-01-01 CN disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 WO disclosed